SLNSW-Pasotuxizumab, a BiTE ® immune therapy for castra...-TN_cdi_proquest_journals_2501458773

Pasotuxizumab, a BiTE ® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings

Full title: Pasotuxizumab, a BiTE ® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings

Author/creator: Hummel, Horst-Dieter, Kufer, Peter, Grüllich, Carsten, Seggewiss-Bernhardt, Ruth, Deschler-Baier, Barbara, Chatterjee, Manik, Goebeler, Maria-Elisabeth, Miller, Kurt, de Santis, Maria, Loidl, Wolfgang, Dittrich, Christian, Buck, Andreas, Lapa, Constantin, Thurner, Annette, Wittemer-Rump, Sabine, Koca, Gökben, Boix, Oliver, Döcke, Wolf-Dietrich, Finnern, Ricarda, Kusi, Helena, Ajavon-Hartmann, Antoinette, Stienen, Sabine, Sayehli, Cyrus Michael, Polat, Bülent, Bargou, Ralf C.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_2501458773

Language: English

Formats: Articles

Publishers: London: Future Medicine Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2501458773

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Pasotuxizumab, a BiTE ® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings

    Record identifier

    TN_cdi_proquest_journals_2501458773

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2501458773

    Share

    Pasotuxizumab, a BiTE ® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2501458773

    Pasotuxizumab, a BiTE ® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings

    Full title

    Pasotuxizumab, a BiTE ® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings

    Author / Creator

    Hummel, Horst-Dieter ; Kufer, Peter ; Grüllich, Carsten ; Seggewiss-Bernhardt, Ruth ; Deschler-Baier, Barbara ; Chatterjee, Manik ; Goebeler, Maria-Elisabeth ; Miller, Kurt ; de Santis, Maria ; Loidl, Wolfgang ; Dittrich, Christian ; Buck, Andreas ; Lapa, Constantin ; Thurner, Annette ; Wittemer-Rump, Sabine ; Koca, Gökben ; Boix, Oliver ; Döcke, Wolf-Dietrich ; Finnern, Ricarda ; Kusi, Helena ; Ajavon-Hartmann, Antoinette ; Stienen, Sabine ; Sayehli, Cyrus Michael ; Polat, Bülent ; Bargou, Ralf C

    Publisher

    London: Future Medicine Ltd

    Journal title

    Immunotherapy, 2021, Vol.13 (2), p.125-141

    Record Identifier

    TN_cdi_proquest_journals_2501458773

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Androgens Antibodies Antigens Biomarkers Bisphosphonates Castration Cytokines Dosage Intravenous administration Lymphocytes Lymphocytes T Medical prognosis Metastasis Patients Pharmacokinetics Prostate cancer Solid tumors Tumor cells Tumors

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_2501458773

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2501458773

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    View in old catalogue

    Connecting people and collections